KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.36 $7.67 Friday, 26th Apr 2024 BPTH stock ended at $2.68. This is 1.71% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 11.20% from a day low at $2.50 to a day high of $2.78.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
Feb 22, 2021 $7.53 $8.24 $7.22 $7.38 1 888 636
Feb 19, 2021 $7.70 $7.78 $7.35 $7.60 1 035 152
Feb 18, 2021 $7.70 $8.64 $7.42 $7.74 2 582 740
Feb 17, 2021 $7.54 $7.59 $7.00 $7.06 1 089 154
Feb 16, 2021 $7.96 $8.04 $7.45 $7.60 2 628 728
Feb 12, 2021 $9.09 $9.40 $8.60 $8.93 701 936
Feb 11, 2021 $11.40 $11.48 $8.60 $9.50 3 374 464
Feb 10, 2021 $15.87 $24.34 $11.29 $11.77 95 232 162
Feb 09, 2021 $5.17 $5.23 $4.92 $5.20 243 090
Feb 08, 2021 $4.78 $5.49 $4.64 $5.18 753 394
Feb 05, 2021 $4.80 $4.84 $4.50 $4.64 211 102
Feb 04, 2021 $4.53 $4.95 $4.49 $4.69 512 428
Feb 03, 2021 $4.44 $4.58 $4.41 $4.48 181 605
Feb 02, 2021 $4.50 $4.57 $4.31 $4.39 196 198
Feb 01, 2021 $4.23 $4.47 $4.11 $4.32 236 554
Jan 29, 2021 $4.08 $4.29 $3.96 $4.14 231 857
Jan 28, 2021 $4.20 $4.33 $4.08 $4.08 235 021
Jan 27, 2021 $4.42 $4.43 $4.04 $4.15 311 675
Jan 26, 2021 $4.46 $4.86 $4.41 $4.55 589 657
Jan 25, 2021 $4.32 $4.44 $4.06 $4.37 295 452
Jan 22, 2021 $4.25 $4.34 $4.17 $4.27 124 391
Jan 21, 2021 $4.38 $4.39 $4.18 $4.33 200 149
Jan 20, 2021 $3.98 $4.36 $3.98 $4.27 568 973
Jan 19, 2021 $4.08 $4.10 $3.95 $3.99 187 811
Jan 15, 2021 $4.05 $4.12 $3.90 $4.05 102 512
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT